Canopy Growth (CGC) Long-Term Investments (2018 - 2026)

Canopy Growth (CGC) reported Long-Term Investments of $78.8 million for Q1 2026, down 37.21% on a YoY basis from $125.4 million in Q1 2025, and down 29.21% sequentially from $111.3 million in Q4 2025.

Canopy Growth (CGC) Long-Term Investments (2018 - 2026) Analysis & Trends

Canopy Growth (CGC) has 9 years of Long-Term Investments data on file, last reported at $78.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Long-Term Investments fell 37.21% year-over-year to $78.8 million; the trailing twelve-month figure through Mar 2026 stood at $78.8 million (down 37.21% YoY), and the FY2026 full-year result was $78.8 million, down 37.21% from the prior year.
  • Long-Term Investments fell to $78.8 million in Q1 2026, from $111.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $324.8 million in Q1 2024 to a low of $24.2 million in Q4 2023.
  • A 5-year average of $91.7 million and a median of $76.6 million in 2026 frame the typical range for Long-Term Investments.
  • Across the five-year window, Long-Term Investments soared 692.78% in 2024 and sank 61.38% in 2025, its largest moves.
  • Tracing CGC's Long-Term Investments over 5 years: stood at $27.3 million in 2022, then dropped by 11.07% to $24.2 million in 2023, then soared by 47.17% to $35.7 million in 2024, then soared by 211.87% to $111.3 million in 2025, then declined by 29.21% to $78.8 million in 2026.
  • Business Quant data shows CGC's Long-Term Investments at $78.8 million in Q1 2026, $111.3 million in Q4 2025, and $137.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 56.09 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.32 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 702.35 Mn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 146.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Canopy Growth 197.77 Mn -68.15 Mn - 78.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 78.76 Mn
Dec 31, 2025 111.26 Mn
Sep 30, 2025 137.38 Mn
Jun 30, 2025 116.85 Mn
Mar 31, 2025 125.43 Mn
Dec 31, 2024 35.67 Mn
Sep 30, 2024 99.97 Mn
Jun 30, 2024 110.16 Mn
Mar 31, 2024 324.77 Mn
Dec 31, 2023 24.24 Mn
Sep 30, 2023 57.44 Mn
Jun 30, 2023 74.48 Mn
Mar 31, 2023 40.97 Mn
Dec 31, 2022 27.26 Mn
Sep 30, 2022 55.21 Mn
Jun 30, 2022 47.06 Mn
Mar 31, 2021 79,009.91
Dec 31, 2020 13.03 Mn
Sep 30, 2020 19.26 Mn
Jun 30, 2020 42.30 Mn